Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US8062627B2 · kind B2 · utility
1Cited by
13References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2008 |
| Grant date | Nov 22, 2011 |
| Priority date | — |
| Expiry date | Sep 13, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.